Attovia Therapeutics, Inc.

NASDAQ:ATTO

Biotechnology

Healthcare
$15.53 -1.20%

-$0.18 today

Market cap
$709.92M
Beta
0.00
P/E (TTM)
-15.9
EPS (TTM)
-$0.86
52W Low $14.23High $28.00

Volume 0.34M

Average 0.45M

ATTO Other Stockholders Equity

Equity items not reported separately, such as additional paid-in capital or treasury stock.

Attovia Therapeutics, Inc.NASDAQ: ATTO

Other Stockholders Equity · Q2 FY2026 · quarter ended Jun 2026

Other stockholders equity of $0 in Q2 FY2026

Q2 FY2026 other stockholders equity was $0.

Context

  • Other stockholders equity amounted to 0.0% of total assets at the end of Q2 FY2026.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterJun 2026
$0— QoQ
Last fiscal yearDec 2025
$0— YoY
Other Stockholders Equity past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Other Stockholders Equity history

USD · from the balance sheet

Latest · FY2025
0 USD
Year-over-year change
—

Other Stockholders Equity vs competitors

How ATTO compares with its peers on the latest reported figures

  • Peers report in different currencies, so other stockholders equity is compared through growth and share of total assets rather than absolute size.
  • Other stockholders equity amounts to 0.0% of total assets for ATTO, versus a peer median of 0.0%.
ATTO Competitors
Other Stockholders Equity for ATTO and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
AGMBAgomAb Therapeutics N.V. American Depositary SharesSep 2025€12.46M EUR——7.5%
ATTOAttovia Therapeutics, Inc.Jun 2026$0 USD——0.0%
ORKAOruka Therapeutics, Inc.Sep 2026$0 USD——0.0%
ANABAnaptysBio, Inc.Mar 2026$0 USD——0.0%
MLTXMoonLake ImmunotherapeuticsMar 2026$0 USD——0.0%
ALMSAlumis Inc. Common StockJun 2026$0 USD——0.0%
ACRSAclaris Therapeutics, Inc.Mar 2026$0 USD——0.0%
EVMNEvommune, Inc.Mar 2026$0 USD——0.0%
QTTBQ32 Bio Inc.Mar 2026$0 USD——0.0%
ZURAZura Bio LimitedMar 2026$0 USD——0.0%
CNTBConnect Biopharma Holdings LimitedDec 2025$0 USD——0.0%
Peer median (excluding ATTO) ———0.0%

Competitors are the stored peer set for ATTO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Attovia Therapeutics, Inc.

NASDAQ:ATTO

Intrinsic Alpha fair value

Locked

Current Price

$15.53

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.